Skip to content

Exacta-Mix 2400 Compounding System, Model Exacta-Mix 2400

by Baxa Corp.

510(k) K002705

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

8 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK002705 Date28 Mar 2001ClearedStatusActive

Recalls

15 recalls · 8 ongoing · FDA

    • Ongoing Z-2262-2026 FDA Class II initiated 22 Apr 2026 on shared 510(k) K002705

    Affected lots may contain incorrect 0.8-micron filters. Use of a 0.8-micron filter in place of the validated 3-micron filter may lead to reduced flow efficiency, incomplete or slower transfers of ingredients, or system alarms. This issue may lead to clinical effects such as electrolyte imbalance, metabolic instability, delayed recovery, etc.

  • 4 recalls, same reason

    • Ongoing Z-3084-2024 FDA Class I initiated 20 Aug 2024
    • Ongoing Z-3082-2024 FDA Class I initiated 20 Aug 2024
    • Ongoing Z-3083-2024 FDA Class I initiated 20 Aug 2024
    • Ongoing Z-3085-2024 FDA Class I initiated 20 Aug 2024

    Baxter Healthcare Corporation has received increased customer reports of particulate matter in the Automated Compounding Device Inlets (disposable inlet), Product Codes H938173, H938174, H938175, H938176, used with the ExactaMix and ExactaMix Pro compounders. Particulate matter has been observed within the inlet primary packaging inlet components, including within the sterile fluid path tubing, before use.

  • 2 recalls, same reason

    • Ongoing Z-1002-2024 FDA Class I initiated 22 Dec 2023
    • Ongoing Z-1001-2024 FDA Class I initiated 22 Dec 2023

    An error was identified in software versions 2.0.8 and 2.1.8 while using the "Use Some Overfill" feature which may lead to over-delivery of an ingredient. This issue can result in redundant ingredient delivery of the requested overfill volume.

    • Ongoing Z-1570-2022 FDA Class II initiated 14 Jul 2022

    There is a potential for leaking valves on ports 1 to 4 in certain lots of valve sets.

  • 4 recalls, same reason

    • Terminated Z-1908-2018 FDA Class II initiated 25 Apr 2018
    • Terminated Z-1911-2018 FDA Class II initiated 25 Apr 2018
    • Terminated Z-1910-2018 FDA Class II initiated 25 Apr 2018
    • Terminated Z-1909-2018 FDA Class II initiated 25 Apr 2018

    Specific lots of EXACTAMIX Inlets listed below due to incorrectly performed over-labeling. The inlets were over-labeled with a blank label, or with a label containing an extended expiration date. If the product is used beyond the expiration date,

    • Terminated Z-1752-2013 FDA Class II initiated 4 Jun 2013

    Baxter Healthcare is recalling certain ExactaMix automated compounding devices due to the complementary metal oxide semi-conductor battery failure resulting in resetting the internal clock of the device to midnight December 31, 2010.

    • Terminated Z-1197-2010 FDA Unclassified (pre-2012) initiated 10 Feb 2010

    Molding defect in the valve body causes leaking.

    • Terminated Z-0210-04 FDA Unclassified (pre-2012) initiated 7 Nov 2003 on shared 510(k) K002705

    If device stops due to an alarm or operater pause, inlet valves will remain open, allowing some unwanted mixing of ingredients in the valve chamber..

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LHI
Device Class
Class II
Regulation
21 CFR Part 880.5440
Advisory Committee
General Hospital
FDA Decision
SESE Substantially Equivalent

Other devices from Baxa Corp.

See all devices from Baxa Corp. →